CD4 and neoplasm: Sahar Mafi et al. (Lastwika et al., 2016) found that PAM inhibition in the nutrient-restricted tumor microenvironment could disrupt the balance between CD4+/CD8+ T cells, T lymphocytes/Th17 cells, and M1/M2 macrophages due to its role in regulating PAM metabolism.